C3G prevents and reverses the hypercholesterolemia-induced endothelial malfunction by suppressing the accumulation of cholesterol and the subsequent decrease in the production of hyperoxides in the aorta (1), thus maintaining eNOS activities and NO bio-availability. Here, NOS3 is linked to Hypercholesterolemia.